Literature DB >> 19039457

Retinal incorporation and differentiation of mesenchymal stem cells intravitreally injected in the injured retina of rats.

Paula Castanheira1, Leonardo Torquetti, Marcio Bittar Nehemy, Alfredo Miranda Goes.   

Abstract

PURPOSE: To evaluate the pattern of retinal integration and differentiation of mesenchymal stem cells (MSCs) injected into the vitreous cavity of rat eyes with retinal injury.
METHODS: Adult rat retinas were submitted to laser damage followed by transplantation of DAPI-labeled BM-MSCs grafts. To assess the integration and differentiation of BM-MSCs in laser-injured retina, host retinas were evaluated 2.4 and 8 weeks after injury/transplantation.
RESULTS: Our results demonstrated that the grafted cells survived in the retina for at least 8 weeks and almost all BM-MSCs migrated and incorporated into the neural retina, specifically in the outer nuclear layer (ONL), inner nuclear layer (INL) and ganglion cell layer (GCL) while a subset of grafted cells were found in the subretinal space posttransplantation. At 8 weeks immunohistochemical analysis with several retinal specific markers revealed that the majority of the grafted cells expressed rhodopsin, a rod photoreceptor marker, followed by parvalbumin, a marker for bipolar and amacrine cells. A few subsets of cells were able to express a glial marker, glial fibrillary acidic protein. However, grafted cells failed to express pan-cytokeratin, a retinal pigment epithelium marker.
CONCLUSIONS: These results suggest the potential of BM-MSCs to differentiate into retinal neurons. Taken together, these findings might be clinically relevant for future mesenchymal stem cell therapy studies concerning retinal degeneration repair.

Entities:  

Mesh:

Year:  2008        PMID: 19039457     DOI: 10.1590/s0004-27492008000500007

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  26 in total

1.  Application of Hanging Drop Culture for Retinal Precursor-Like Cells Differentiation of Human Adipose-Derived Stem Cells Using Small Molecules.

Authors:  Hossein Salehi; Shahnaz Razavi; Ebrahim Esfandiari; Mohammad Kazemi; Shahram Amini; Noushin Amirpour
Journal:  J Mol Neurosci       Date:  2019-07-30       Impact factor: 3.444

Review 2.  Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.

Authors:  Hongjun Du; Siok Lam Lim; Seanna Grob; Kang Zhang
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

3.  Neuroprotective effects of BDNF and GDNF in intravitreally transplanted mesenchymal stem cells after optic nerve crush in mice.

Authors:  Zong-Li Hu; Ni Li; Xin Wei; Li Tang; Ting-Hua Wang; Xiao-Ming Chen
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

Review 4.  Stem cell therapy for retinal diseases: update.

Authors:  Rubens Camargo Siqueira
Journal:  Stem Cell Res Ther       Date:  2011-12-29       Impact factor: 6.832

5.  Keratinocyte growth factor-2 and autologous serum potentiate the regenerative effect of mesenchymal stem cells in cornea damage in rats.

Authors:  Ferda Alpaslan Pınarlı; Gülsen Okten; Umit Beden; Tunç Fışgın; Mehmet Kefeli; Nurten Kara; Feride Duru; Leman Tomak
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

Review 6.  Stem cell-based therapies for age-related macular degeneration: current status and prospects.

Authors:  Yalin Mu; Manli Zhao; Guangming Su
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 7.  Revisiting the role of erythropoietin for treatment of ocular disorders.

Authors:  S L Shirley Ding; S N Leow; R Munisvaradass; E H Koh; M L C Bastion; K Y Then; S Kumar; P L Mok
Journal:  Eye (Lond)       Date:  2016-06-10       Impact factor: 3.775

Review 8.  Promises of stem cell therapy for retinal degenerative diseases.

Authors:  Ian Yat-Hin Wong; Ming-Wai Poon; Rosita Tsz-Wai Pang; Qizhou Lian; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-25       Impact factor: 3.117

Review 9.  Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges.

Authors:  Rosa M Coco-Martin; Salvador Pastor-Idoate; Jose Carlos Pastor
Journal:  Pharmaceutics       Date:  2021-06-11       Impact factor: 6.321

10.  Stem cell therapy in retinal diseases?

Authors:  Rubens Camargo Siqueira
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.